Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Umbrella for platform providers

Former Perkin-Elmer Corp. president and COO Riccardo Pigliucci believes he has found one solution to the proliferation of small service-oriented toolkit companies that possess pieces of interesting technology but lack the critical mass to make it on their own.

Pigliucci is CEO of the newly formed Discovery Partners International, which aggregates combinatorial chemistry company Irori and ChemRx, a chemical libraries and lead-optimization company. The two companies, which will be independent

Read the full 690 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers